-
Q2FY22 India Inc earnings show that inflation isn’t transient
Going by market reactions to Q2 performance so far, it appears that investors are suddenly waking up to the harsh reality inflation isn’t transient.
-
Four new IPOs leave investors spoilt for choice; which one should you pick for your portfolio?
Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech are going to raise close to Rs 3,614 crore between August 4 and 6
-
Prefer Glenmark Life over Rolex Rings for the long-term: Vinit Bolinjar
Glenmark Life Sciences IPO is open for subscription from July 27 to July 29, with a price band of Rs 695-720 per share
-
Expect Zomato to be EBITDA positive by FY25: Vinit Bolinjkar
Zomato will evolve into a much bigger story than just food delivery
-
'Markets will be best placed for growth among EMs'
We will actually see all sectors performing well on positive triggers benefitting the overall economic growth especially the rural segment: Bolinjkar
-
It's a splendid time to book profits: Vinit Bolinjkar
Investors can look to add stocks where secular growth is coming and valuations are comfortable, says Vinit Bolinjkar
